Articles that mention Pfizer -BoardProspects

Pfizer

0 Comments Leave a Comment

1-15 of 27 1 2 »
1. Mentioned In 27 Articles
2. Pfizer's Long-Serving CEO Ian Read is Standing Down and Being Replaced by his Chief Operating Officer
  
  Explore Business Insider Oct 1 2018 BoardNews
  
  ...chief operating officer. After standing down as both CEO and chairman, Read will become executive chairman of Pfizer's board of directors. "It's been an honor to serve as Pfizer's CEO for the past eight years," Read said...
  Read Full Article
  
  Comment
  
  Mentions: CEO Pfizer Albert Bourla
3. Institutional Investors Call on Manufacturers to Oppose Attacks on Shareholder
  
  Explore Pensions & Investments Aug 31 2018 BoardNews
  
  ...ainability of the company," said a letter sent in July to Kirsten Lund-Jurgensen, executive vice president of Pfizer Inc. The letter's content was the same or similar to those sent to other corporations, including Exxon ...
  Read Full Article
  
  Comment
  
  Mentions: Corporate Governance Management Investors
4. Palleon Pharmaceuticals Appoints Lori Hu of Vertex Ventures HC to Board of Directors
  
  Explore businesswire.com Jun 21 2018 BoardMoves
  
  ...d development programs with a $47.6 million Series A financing from leading biotech venture investors SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, and AbbVie Ventures. Learn more at www.palleonpharma.com...
  Read Full Article
  
  Comment
  
  Mentions: CEO Bristol-Myers Squibb MBA
5. Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
  
  Explore CNBC.com May 29 2018 BoardMoves
  
  ...ire Therapeutics, Inc.(GEMP), an early-stage cardiovascular drug company formed by a licensing agreement with Pfizer Inc. He also is Chairman of the Board of privately held ComHear Inc., a digital audio software and devi...
  Read Full Article
  
  Comment
  
  Mentions: Board of Trustees Leadership Technology
6. Despite 34% Cut, AstraZeneca Shareholders Still Don't Like CEO Soriot's £9.4M Pay
  
  Explore Pharma News May 21 2018 BoardNews
  
  ...s pay more closely to the financial targets he set back when he was scrambling to avoid a hostile takeover by Pfizer, namely the £45-billion-by-2023 revenue target he quoted to investors at the time. It’s not as if those...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Investors CEO
7. LiveWorld: Appoints Seasoned Healthcare and Venture Capital Professionals to Board of Directors
  
  Explore 4-traders : one website, all markets Apr 25 2018 BoardMoves
  
  ...o their customers to bolster relationships, loyalty, and lifetime value. Our clients include Bank of America, Pfizer, Wells Fargo, and Zoetis, among others. Visit www.liveworld.com to learn more or contact us at @LiveWor...
  Read Full Article
  
  Comment
  
  Mentions: CEO Wells Fargo IBM
8. P&G to Buy German Merck’s Consumer Unit for $4.2 Billion
  
  Explore Bloomberg Apr 19 2018 BoardNews
  
  ...erest in a consumer joint venture to partner GlaxoSmithKline Plc, gaining cash to invest in innovative drugs. Pfizer is reviewing its options after the sale of its consumer-health business fizzled in March, with potentia...
  Read Full Article
  
  Comment
  
  Mentions: CEO Mylan Amazon
9. Which Big Pharma CEOs Least Deserved Their Big Pay Increases?
  
  Explore Fool.com Apr 4 2018 BoardBlogs
  
  ...ow shareholder value. My view is that it's hard to justify the exorbitant increase in total compensation that Pfizer gave Ian Read. It's not that Read hasn't been a pretty good CEO. I just think there are plenty of indiv...
  Read Full Article
  
  Comment
  
  Mentions: Management CEO Bristol-Myers Squibb
10. GlaxoSmithKline Buys Novartis out of Their Joint Venture for $13 Billion
  
  Explore Business Insider Mar 27 2018 BoardNews
  
  ... expected 2018 core earnings for the joint venture stake, while sources have told Reuters that both Merck and Pfizer had asked for up to 20 times for their respective assets. Yet analysts at Baader Helvea welcomed the ca...
  Read Full Article
  
  Comment
  
  Mentions: CEO Amazon Barclays
11. Albert Bourla Elected to Pfizer's Board of Directors
  
  Explore businesswire.com Feb 23 2018 BoardMoves
  
  ...d follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer. Pfizer Inc. Media: Joan Campion, 212-733-2798 Investors: Ryan Crowe, 212-733-8160 Pfizer Inc. Media: J...
  Read Full Article
  
  Comment
  
  Mentions: Investors Twitter Facebook
12. Sanofi is Buying Another Blood-Disease Biotech for $4.8 Billion
  
  Explore Business Insider Jan 29 2018 BoardNews
  
  ...ts past failure to land big deals. Sanofi lost out on buying California-based cancer specialist Medivation to Pfizer in 2016, and also missed acquiring Swiss biotech company Actelion, which was bought by Johnson & Johnso...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi acquisition Morgan Stanley
13. Predictive Technology Group Appoints Dr. Michael Dey To Board Of Directors
  
  Explore NASDAQ Stock Market Jan 2 2018 BoardMoves
  
  ...ly owned subsidiary of PRED. Before joining PRED, Dr. Dey had executive positions at Wyeth, later acquired by Pfizer, where he was both the President and the President of Scientific Affairs division for Wyeth's Women's H...
  Read Full Article
  
  Comment
  
  Mentions: Board Recruitment Investor Relations Technology
14. Neuralstem Announces the Appointment of Two New Members to the Board of Directors
  
  Explore GlobeNewswire Sep 26 2017 BoardMoves
  
  ...cipal at Clarus Ventures LLC, and held roles in Clinical Development and Translational Research at Wyeth (now Pfizer), Genetics Institute and Dana Farber Cancer Institute. Dr. Csimma holds both a Doctor of Pharmacy and a...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Corporate Governance CEO
15. Ligand Appoints Dr. Nancy Gray to its Board of Directors
  
  Explore businesswire.com Aug 21 2017 BoardMoves
  
  ...er business relationships with the world’s leading pharmaceutical companies including Novartis, Amgen, Merck, Pfizer, Celgene, Gilead, Janssen, Baxter International and Eli Lilly. Follow Ligand on Twitter @Ligand_LGND. L...
  Read Full Article
  
  Comment
  
  Mentions: Twitter Amgen Pfizer
16. GlycoMimetics Appoints Boston Biomedical CEO Patricia S. Andrews to Its Board of Directors
  
  Explore CNBC.com Jun 12 2017 BoardMoves
  
  ...ell disease and is being evaluated in a Phase 3 clinical trial being conducted by its strategic collaborator, Pfizer. GlycoMimetics' wholly-owned drug candidate, GMI-1271, an E-selectin antagonist, is being evaluated in ...
  Read Full Article
  
  Comment
  
  Mentions: CEO Pfizer Chairman
17. 1-15 of 27 1 2 »

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Related Topics
1. Yahoo! Names Thompson CEO
  130 articles also mentioned Chairman
2. Shantanu Narayen Elected To Pfizer's Board Of Directors
  75 articles also mentioned CEO
3. Chrysler Adds Two to Board
  37 articles also mentioned AT&T
4. Molson Coors Adds Two to Board
  33 articles also mentioned Europe
5. Thompson Joins Microsoft Board
  30 articles also mentioned Johnson & Johnson
Quotes about Pfizer
1. We are pleased to welcome Shantanu Narayen to Pfizer's Board of Directors. He brings both leadership experience and a strong technology background to Pfizer's Board and will be an excellent asset to the company.
  Ian Read in Shantanu Narayen Elected To Pfizer's Board Of Directors
2. We are pleased to have Jim Smith join Pfizer's Board of Directors. He brings leadership and operational and international business experience to Pfizer's Board, and will be an excellent asset to the company.
  Ian Read in James C. Smith Elected to Pfizer’s Board of Directors
3. Amy is a recognized leader in the development and growth of global pharmaceutical businesses, and she will bring this expertise to our Board as we continue to build Alnylam as a leading biotechnology company. As the former General Counsel at Pfizer, Amy also brings deep legal expertise to our Board.
  In Alnylam Elects Amy Schulman to its Board of Directors

Mentioned In 27 Articles

Categories

BoardProspects Features:

Related Topics

Quotes about Pfizer